Top Markets
Coin of the day
Fennec Pharmaceuticals Inc. Fennec Pharmaceuticals Inc.

Fennec Pharmaceuticals Inc.

FENC
Rank in Stocks #14209
Fennec Pharmaceuticals Inc. operates as a biopharmaceutical firm. Its leading... Fennec Pharmaceuticals Inc. operates as a biopharmaceutical firm. Its leading investigational drug in clinical development is PEDMARK, a specialized formulation of sodium thiosulfate. This treatment is designed to shield young cancer patients from hearing damage (ototoxicity) that can be induced by platinum-based chemotherapy. The company, which was founded in 1996, previously operated under the name Adherex Technologies Inc. before officially rebranding as Fennec Pharmaceuticals Inc. in September 2014. Its corporate headquarters are situated in Research Triangle Park, North Carolina.
Share Price
$12.33
Market Cap
$428.31M
Change (1 day)
0.49%
Change (1 year)
39.01%
Country
US
Trade Fennec Pharmaceuticals Inc. (FENC)

Category

Stock price history for Fennec Pharmaceuticals Inc. (FENC)
Highest end of day price: $11.76 on 2026-08-01

Lowest end of day price: $11.52 on 2017-09-01
Stock price history of Fennec Pharmaceuticals Inc. from 2017 to 2026
Annual Stock Price Performance
Year Performance
2026 (TTM) 11.99%
2025 25.75%
2024 -39.44%
2023 2.87%
2022 131.45%
2021 -44.21%
2020 23.34%
2019 -0.18%
2018 -33.41%
2017 0.00%
Stock price for similar companies or competitors
Company Stock price Change 1y% Country
$544.38 39.22%
US
$1.03K 45.21%
NL
$121.01 -12.20%
AU
$138.80 476.17%
US
$749.90 5.10%
CH